N/A
N=111
Assess Vitamin D Levels in Those With & Without Thyroid Cancer
Thyroid Cancer
Bottom Line
View on ClinicalTrials.gov: NCT00719615 ↗Enrolled (actual)
111
Serious AEs
0.0%
Results posted
Mar 2010
Primary outcome: Primary: Number of Persons That Are Vitamin D Deficient in the Thyroid Nodule, Thyroid Cancer in Remission, and the Active Thyroid Cancer Groups. — 23; 20; 11 participants — p=<0.05
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- —
- Age
- Adult, Older Adult · 19+ yrs
- Sex
- All
- Sponsor
- University of Nebraska
- Primary completion
- Mar 2009
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Persons That Are Vitamin D Deficient in the Thyroid Nodule, Thyroid Cancer in Remission, and the Active Thyroid Cancer Groups. |
23; 20; 11 | <0.05 sig |
Summary
The purpose of this study is to evaluate Vitamin D levels in thyroid cancer patients with active disease compared with thyroid cancer patients in remission and patients with thyroid nodules.
Eligibility Criteria
Inclusion Criteria
- Cases: History of Papillary, Follicular, Follicular Variant of Papillary, or Hurthle cell thyroid cancer (both active disease and in remission).
- Controls: Individuals with a thyroid nodule, matched to cases for age, BMI, season of vitamin D measurement.
- Participating in University of Nebraska Medical Center Thyroid Tumor and Cancer Collaborative Registry database.
Exclusion Criteria
- Pregnant or breast feeding women
- Medullary thyroid cancer
- Anaplastic thyroid cancer
Data sourced from ClinicalTrials.gov (NCT00719615). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.